在轻度至中度镇静和止痛后,固的低氧症:一个病例报告
Jiayun Zou1, Huazhen Wang1, Yongshan Nan2
1Department of Anesthesiology, Yanbian University, Yanbian University Hospital, Yanji, Jilin, P.R. China.
Medicine
|February 16, 2024
概括
外科手术期间的脱氧症可能导致耐火性低氧症,特别是在患有先前存在的肺部疾病的患者中,他们接受非输入式麻醉. 个性化氧气和药物治疗策略对于患者的安全至关重要.
科学领域:
- 麻醉学 麻醉学
- 肺部病理学 肺部病理学
- 临界护理医学 临界护理医学
背景情况:
- 肺部区域的崩 (atelectasis) 会损害呼吸功能,并且经常被诊断不足,特别是在全身麻醉后.
- 本案例研究研究了肝瘤患者静止后和止痛后的耐火性低氧症,突出了非输管手术期间的潜在风险.
研究的目的:
- 为了分析肝脏瘤患者内科手术时发生的抗氧化症病例.
- 为了强调与在肺部疾病中非输管麻醉相关的风险.
主要方法:
- 延平大学附属医院的一例患者病例的回顾分析.
- 利用CT检查和病史进行诊断.
- 在手术后监测生命体征,并给予氧气治疗和雾化吸入.
主要成果:
- 一名被诊断患有手术期间的骨质疏松症的患者.
- 手术后的肺不透明度从9.2%降至胸面积的8.4%.
- 随着干预,生命体征恢复到基线.
结论:
- 肺部受损的患者在非输管静脉麻醉期间容易患上耐火性低氧症.
- 个性化氧气度,药物和呼吸道管理至关重要.
- 积极的气道管理对于患者的安全至关重要.
更多相关视频
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
2.8K
07:54Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
19.8K
相关概念视频
Stages of General Anesthesia
444
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
444
Parenteral Anesthetics: Overview
125
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
125
Respiratory Assessment: Purpose and Indications
1.1K
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.1K
Acute Respiratory Failure-IV
157
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
157
Acute Respiratory Failure-II
228
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
228
Acute Respiratory Failure-III
185
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
185
